NCT00328068

Brief Summary

Background: Existing criteria for AS/SpA such as mod. New York, ESSG, or Amor criteria for classification and/or diagnosis of spondyloarthritis have limitations when applied to early disease. Moreover, MRI is not part of any of the established criteria and the precise role of MRI in early axial disease has not been fully defined yet. Even less is known about sacroiliac (SI) changes in SpA patients with peripheral symptoms. A pilot study using data from 'paper patients' led to new candidate criteria for early spondyloarthritis. Subsequently, the members of the ASAS International Working Group decided to conduct a prospective multi-centre study to evaluate (validate) the new candidate criteria, and to assess their performance as diagnostic criteria. Aims of the study:

  1. 1.To evaluate the new candidate criteria for axial SpA in a multi-centre setting.
  2. 2.To assess the potential role of the new candidate criteria to be used as diagnostic criteria. To accomplish this, inclusion of consecutive and undiagnosed patients is mandatory as are longer periods of follow-up .
  3. 3.To compare criteria encompassing the whole group of SpA such as ESSG and Amor criteria against criteria which are tailored to either predominant axial disease or predominant peripheral disease. To accomplish this, both patients with predominant axial disease (back pain) but also patient with predominant peripheral disease (arthritis/enthesitis) will be included.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
992

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2006

Longer than P75 for all trials

Geographic Reach
20 countries

35 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 18, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 19, 2006

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2006

Completed
6.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2013

Completed
Last Updated

February 13, 2013

Status Verified

February 1, 2013

Enrollment Period

6.9 years

First QC Date

May 18, 2006

Last Update Submit

February 12, 2013

Conditions

Keywords

ASAS classificationASAS diagnostic criteriaspondyloarthritisspondyloarthropathyspondylitis, ankylosingmodified New York criteria for ASESSG criteria for SpAAmor criteria for SpAarthritisenthesitismagnetic resonance imaging

Outcome Measures

Primary Outcomes (1)

  • Diagnosis of Spondyloarthritis

    2 years

Secondary Outcomes (1)

  • Patients with a retained diagnosis of spondyloarthritis after follow-up

    2-5 years

Study Arms (1)

Back pain / peripheral arthritis

Patients with chronic back pain of unknown origin and onset of back pain \<45 years of age or patients with peripheral arthritis / enthesitis / dactylitis of unknown origin and onset \<45 years of age

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with chronic back pain of unknown origin or peripheral arthritis / enthesitis / dactylitis of unknown origin who are referred to a rheumatologist for diagnostic work-up

You may qualify if:

  • Include newly referred patients if:
  • Onset of symptoms (back pain/arthritis/enthesitis) \< 45 years
  • Undiagnosed disease with the following symptoms:
  • chronic back pain (duration of back pain more than 3 months)
  • and/or peripheral arthritis (asymmetric arthritis/predominantly of the lower limbs)
  • and/or enthesitis
  • and/or dactylitis

You may not qualify if:

  • Definite diagnosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (35)

Case Western Reserve University at MetroHealth Medical Centre

Cleveland, Ohio, 44109, United States

NOT YET RECRUITING

University Hospital Gent

Ghent, B-9000, Belgium

RECRUITING

Rheumatology Division

São Paulo, Brazil

NOT YET RECRUITING

University of Alberta

Edmonton, Alberta, T6G 252, Canada

RECRUITING

The Toronto Hospital

Toronto, Ontario, ON M5T 2S8, Canada

NOT YET RECRUITING

Chinese PLA General Hospital

Beijing, 100853, China

RECRUITING

Third Affiliated Hospital of Sun Yat-sen University

Guangzhou, 510630, China

RECRUITING

Division of Rheumatology

Bogotá, Colombia

RECRUITING

Hvidovre Hospital, University of Copenhagen

Hvidovre, 2650, Denmark

RECRUITING

Service de Rheumatologie

Marseille, France

NOT YET RECRUITING

Rheumatology B Department

Paris, 75014, France

RECRUITING

Brandt

Berlin, 12163, Germany

RECRUITING

Universitaetsmedizin Berlin, Charité Campus Benjamin-Franklin, Med. Clinic I, Rheumatology, Hindenburgdamm 30

Berlin, 12200, Germany

RECRUITING

Rheumazentrum Ruhrgebiet

Herne, 44625, Germany

RECRUITING

Géher

Budapest, H-1027, Hungary

NOT YET RECRUITING

Seroja Rheumatic Centre

Semarang, 50241, Indonesia

NOT YET RECRUITING

St. Vincent's Hospital

Dublin, 4, Ireland

RECRUITING

University of Florence

Florence, 50122, Italy

RECRUITING

Arcispedale S. Maria Nouva

Reggio Emilia, 422100, Italy

RECRUITING

Caterina Naclerio

Scafati (SA), Italy

RECRUITING

Hospital General de México

Mexico City, DF 06726, Mexico

NOT YET RECRUITING

VU University Medical Center

Amsterdam, 1081 HV, Netherlands

RECRUITING

Kennemer Gasthuis, Locatie Deo

HG IJmuiden, 1971, Netherlands

RECRUITING

University Hospital Maastricht

Maastricht, 6229 HX, Netherlands

RECRUITING

Hospital Universitario "Reina Sofia"

Córdoba, 14004, Spain

RECRUITING

Hospital Universitario Gregorio Marañón

Madrid, 28007, Spain

NOT YET RECRUITING

Balgrist University Hospital

Zurich, 8008, Switzerland

RECRUITING

Veterans General Hospital Taipei

Beitou Dist. Taipei, 112, Taiwan

RECRUITING

Wei

Taichung, 40201, Taiwan

RECRUITING

Duruöz

Bornova, 35050, Turkey (Türkiye)

RECRUITING

Division of Rheumatology

Elâzığ, Turkey (Türkiye)

RECRUITING

Izmir University Hospital

Izmir, Turkey (Türkiye)

RECRUITING

Glasgow Royal Infirmary, Queen Elizabeth Building

Glasgow, G31 2 ER, United Kingdom

NOT YET RECRUITING

King George Hospital

Goodmayes, IG3 8YB, United Kingdom

RECRUITING

ChapelChapel Allerton Hospital

Leeds, LS7 4SA, United Kingdom

RECRUITING

Related Publications (3)

  • Rudwaleit M, Metter A, Listing J, Sieper J, Braun J. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum. 2006 Feb;54(2):569-78. doi: 10.1002/art.21619.

    PMID: 16447233BACKGROUND
  • Rudwaleit M, Sieper J. Positive and negative predictive values from published studies can be misleading for decision-making in clinical practice. Rheumatology (Oxford). 2006 Jun;45(6):779-80; author reply 780-1. doi: 10.1093/rheumatology/kel083. Epub 2006 Apr 4. No abstract available.

    PMID: 16595519BACKGROUND
  • Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, Sorensen IJ, Ozgocmen S, Roussou E, Valle-Onate R, Weber U, Wei J, Sieper J. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009 Jun;68(6):777-83. doi: 10.1136/ard.2009.108233. Epub 2009 Mar 17.

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

DNA and RNA will be collected in selected centres for analysis of candidate gene variants in ankylosing spondylitis/ spondyloarthritis. Serum and plasma sample will be collected for biomarker analysis with special focus on markers of bone metabolism

MeSH Terms

Conditions

SpondylarthritisSpondylarthropathiesSpondylitis, AnkylosingArthritis

Condition Hierarchy (Ancestors)

SpondylitisSpinal DiseasesBone DiseasesMusculoskeletal DiseasesJoint DiseasesAxial SpondyloarthritisAnkylosis

Study Officials

  • Martin Rudwaleit, MD

    Universitatsmedizin Berlin, Charité Campus Benjamin-Franklin, Med. Clinic I, Rheumatology, Hindenburgdamm 30, 12200 Berlin, Germany

    PRINCIPAL INVESTIGATOR
  • Joachim Sieper, MD

    Charité Universtaetsmedizin Berlin

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.

Study Record Dates

First Submitted

May 18, 2006

First Posted

May 19, 2006

Study Start

July 1, 2006

Primary Completion

June 1, 2013

Study Completion

June 1, 2013

Last Updated

February 13, 2013

Record last verified: 2013-02

Locations